Cibc World Markets Corp Atea Pharmaceuticals, Inc. Transaction History
Cibc World Markets Corp
- $12.4 Billion
- Q1 2025
A detailed history of Cibc World Markets Corp transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Cibc World Markets Corp holds 17,122 shares of AVIR stock, worth $54,619. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,122Holding current value
$54,619% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AVIR
# of Institutions
109Shares Held
48.3MCall Options Held
3.4KPut Options Held
14.5K-
Black Rock Inc. New York, NY9.12MShares$29.1 Million0.0% of portfolio
-
Bml Capital Management, LLC Zionsville, IN7.61MShares$24.3 Million18.41% of portfolio
-
Tang Capital Management LLC San Diego, CA4.8MShares$15.3 Million0.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$15.1 Million0.0% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.49MShares$7.93 Million2.49% of portfolio
About Atea Pharmaceuticals, Inc.
- Ticker AVIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,258,600
- Market Cap $266M
- Description
- Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...